Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Clinical validity of NGS and innovation in clinical diagnosis

Dr Jeffrey Ross - Albany Medical College, Albany, USA
Clinical validity of NGS and innovation in clinical diagnosis ( Dr Jeffrey Ross - Albany Medical College, Albany, USA )
21 Feb 2018

6-factor prognostic model for patients with advanced urothelial carcinoma

Dr Gregory Pond - McMaster University, Hamilton, Ontario
6-factor prognostic model for patients with advanced urothelial carcinoma ( Dr Gregory Pond - McMaster University, Hamilton, Ontario )
9 Feb 2018

Comment: Urothelial cancer research from ASCO GU 2018

Dr Guru Sonpavde - Dana-Farber Cancer Institute, Boston, USA
Comment: Urothelial cancer research from ASCO GU 2018 ( Dr Guru Sonpavde - Dana-Farber Cancer Institute, Boston, USA )
9 Feb 2018

Genomic profiling of muscle invasive bladder cancer to predict response to bladder-sparing trimodality therapy

Dr David Miyamoto - Massachusetts General Hospital, Boston, USA
Genomic profiling of muscle invasive bladder cancer to predict response to bladder-sparing trimodality therapy ( Dr David Miyamoto - Massachusetts General Hospital, Boston, USA )
9 Feb 2018

Tumour fraction in circulating free DNA as a biomarker of disease dynamics in metastatic prostate cancer

Dr Atish Choudhury - Dana-Farber Cancer Institute, Boston, USA
Tumour fraction in circulating free DNA as a biomarker of disease dynamics in metastatic prostate cancer ( Dr Atish Choudhury - Dana-Farber Cancer Institute, Boston, USA )
9 Feb 2018

Crizotinib for advanced papillary renal cell carcinoma with MET mutations or amplification

Prof Patrick Schöffski - The Katholieke Universiteit Leuven, Leuven, Belgium
Crizotinib for advanced papillary renal cell carcinoma with MET mutations or amplification ( Prof Patrick Schöffski - The Katholieke Universiteit Leuven, Leuven, Belgium )
9 Feb 2018

Serum miRNA to predict post-chemotherapy viable disease in testicular non-seminomatous germ cell tumour patients

Dr Ricardo Leão - University of Toronto, Toronto, Canada
Serum miRNA to predict post-chemotherapy viable disease in testicular non-seminomatous germ cell tumour patients ( Dr Ricardo Leão - University of Toronto, Toronto, Canada )
8 Feb 2018

Radium-223 for bone predominant metastatic castration resistant prostate cancer

Dr Andrew Armstrong - Duke University School of Medicine, Durham, USA
Radium-223 for bone predominant metastatic castration resistant prostate cancer ( Dr Andrew Armstrong - Duke University School of Medicine, Durham, USA )
8 Feb 2018

Latest in adjuvant therapy for renal cell carcinoma

Dr Naomi Haas - University of Pennsylvania, Philadelphia, USA
Latest in adjuvant therapy for renal cell carcinoma ( Dr Naomi Haas - University of Pennsylvania, Philadelphia, USA )
8 Feb 2018

Hypoxia related mRNA biomarker to predict biochemical failure and metastasis for prostate cancer

Dr Ananya Choudhury - The Christie NHS Foundation Trust, Manchester, UK
Hypoxia related mRNA biomarker to predict biochemical failure and metastasis for prostate cancer ( Dr Ananya Choudhury - The Christie NHS Foundation Trust, Manchester, UK )
8 Feb 2018

Detection and clinical significance of dense breast tissue

Prof Wendy Ingman - The University of Adelaide, Adelaide, Australia
Detection and clinical significance of dense breast tissue ( Prof Wendy Ingman - The University of Adelaide, Adelaide, Australia )
6 Feb 2018

Challenges in cervical radiotherapy

Prof Fady Geara - American University of Beirut Medical Center, Beirut, Lebanon
Challenges in cervical radiotherapy ( Prof Fady Geara - American University of Beirut Medical Center, Beirut, Lebanon )
29 Jan 2018